(Q24291677)

Prostaglandin I2 synthase

GOA release 2020-03-11

1 reference

positive regulation of execution phase of apoptosis

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author name string

T Hatae

1

0 references

M Wada

2

0 references

C Yokoyama

3

0 references

M Shimonishi

4

0 references

T Tanabe

Journal of Biological Chemistry

5

0 references

language of work or name

English

0 references

publication date

7 December 2001

0 references

published in

0 references

volume

276

0 references

issue

49

0 references

page(s)

46260-7

0 references

cites work

Cyclooxygenases: structural, cellular, and molecular biology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Prostacyclin and thromboxane synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Distribution and function of prostanoid receptors: studies from knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Prostaglandins and thromboxanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Agonist-dependent phosphorylation of an epitope-tagged human prostacyclin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Pharmacodynamic profile of prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Molecular biology of prostanoid receptors; an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Self-promotion? Intimate connections between APC and prostaglandin H synthase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Adipogenesis and obesity: rounding out the big picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Alterations of peroxisome proliferator-activated receptor delta activity affect fatty acid-controlled adipose differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Site-directed mutagenesis of human prostacyclin synthase: Alteration of Cys441 of the Cys-pocket, and Glu347 and Arg350 of the EXXR motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Daxx, a novel Fas-binding protein that activates JNK and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

H-series protein kinase inhibitors and potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Hormone signal response system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

7 January 2021

Apoptosis meets signal transduction: elimination of a BAD influence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

7 January 2021

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

7 January 2021

Opposite regulation of PPAR-α and -γ gene expression by both their ligands and retinoic acid in brown adipocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

7 January 2021

Progress in cardiovascular biology: PPAR for the course

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

7 January 2021

Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

7 January 2021

Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

7 January 2021

A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

7 January 2021

Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

7 January 2021

Prostanoid receptors: structures, properties, and functions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

7 January 2021

Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107180200

7 January 2021